Science and Evidence | Hoxsey Formula

The central finding is straightforward: the complete Hoxsey regimen has not been shown in reliable clinical research to prevent, treat, or cure cancer.

Bottom line

Question	What the evidence supports
Does the complete regimen treat cancer?	No reliable clinical evidence establishes benefit.
Have ingredients shown biological activity?	Some compounds have shown effects in cells, animals, or studies for other outcomes. That does not prove the mixture treats cancer.
Was it “never tested”?	No adequate controlled human trial is established. A 1952 appellate record nevertheless describes controlled mouse testing that found no benefit.
Did a court prove it worked?	No. Litigation addressed libel and regulatory claims, not clinical efficacy. The 1952 appellate court directed an injunction against false and misleading treatment claims.

Why ingredient studies are not regimen evidence

A plant can contain a compound that affects cancer cells in a laboratory without being a safe or effective cancer treatment. Dose, absorption, metabolism, interactions, tumor type, and the other ingredients all matter. Evidence for an isolated compound cannot be transferred to a proprietary mixture without testing that mixture in patients.

One frequently cited example is a randomized trial in which berberine reduced recurrence of colorectal adenomas after polypectomy. Adenomas are precancerous growths; preventing their recurrence is not the same as treating cancer, and berberine alone is not the Hoxsey tonic.

What historical testing found

In United States v. Hoxsey Cancer Clinic (1952), the Fifth Circuit described a controlled mouse experiment involving the clinic's liquid and powder preparations. The court said the results showed no benefit and that credible evidence overwhelmingly supported the conclusion that efficacy representations were false and misleading. It directed the lower court to issue an injunction.

This animal experiment cannot settle every question about human outcomes. It does, however, make the categorical claim that the treatment “was never tested at all” inaccurate.

How to interpret the 1990 OTA report

The U.S. Office of Technology Assessment's Unconventional Cancer Treatments documented Hoxsey's history and discussed research on plant components. It did not conclude that the regimen cures cancer. The report repeatedly distinguishes interesting constituents and traditional uses from reliable evidence about the treatment itself.

The topical paste is not Mohs surgery

Historical Hoxsey topical preparations and early Mohs chemosurgery both involved caustic materials. That chemical overlap does not make them equivalent. Mohs surgery is a staged surgical procedure with microscopic examination of tissue margins; the microscopy and controlled excision are essential. Applying an escharotic paste alone can destroy healthy tissue, scar or disfigure, obscure remaining cancer, and delay effective care.

This archive intentionally does not provide quantities or preparation instructions.

Evidence hierarchy used here

Controlled clinical outcomes: the most relevant evidence for whether a treatment helps patients.
Observational reports and case series: useful for signals, but vulnerable to selection, diagnosis, follow-up, and comparison problems.
Animal and laboratory studies: useful for hypotheses, not proof of clinical benefit.
Testimonials, memoirs, legal arguments, and political allegations: historically relevant, but not efficacy evidence.